Hello, everyone, and how are you today? A patch of clouds is looming over the Pharmalot corporate campus, but we will not let that deter us. There is, after all, too much to do. You know, deadlines and meetings and reading all sorts of things. So please join us as we reach for that mandatory cup of stimulation - our flavor today is Pumpkin Spice - and dig in. And of course, here are some tidbits. Have a great day...
Astellas Ends Development Of Anti-Clotting Drug (Reuters)
Alcon Seeks Incentives To Expand, Add Jobs (Fort Worth Star-Telegram)
Watson CEO Complains FDA Scrutiny Causes Shortages (Financial Times)
Teva Exec Says Cephalon Deal Is Still On Track (Philadelphia Inquirer)
India Panel Recommends Against Curbs On Foreign Investment In Pharma (Economic Times)
Merck Names New Chief Strategy Officer (The Star-Ledger Of New Jersey)
Merck's Gardasil Beats Glaxo HPV Vaccine On Cost In UK (Bloomberg News)
Rick Perry And His HPV Vaccine E-mails (The Huffington Post)
Novo Seeks US And EU Approval For Degludec Insulin (Dow Jones)
University Of Iowa Files Patent Suit Against MedImmune (Press Citizen)
Australian Uproar Over Promoting Diet Supplements With Meds (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning
Coffee pix thx to chichcacha flickr creative commons
1 Comment
Ed- I tried the Pumpkin Spice coffee due to this piece. I'm addicted and converted. Absolutely yummy.